Croatian-Swiss Partner Search for Eurostars

12 Mar 2023 – 10 Mar 2024

InvestmentUpdated on 21 November 2023

A biomolecule for treating life threatening women's health conditions

Alexey Borozna

Advisor at Branson Pharma AG

Baar, Switzerland

About

  • Branson Pharma develop a bio molecule that demonstrates a high efficacy and speed to eliminate a range of infections related to gynecologic conditions in uterus and fallopian tubes (endometritis, endometriosis, adenomyosis, etc.)

  • The molecule specifically targets infected cells only, dissolving dead and infected tissue by breaking any infection down into basic amino acids and removing them

  • Early tests demonstrated a significant efficacy closer to 100% treatment rate

  • At Branson Pharma we believe the final product can be called a cure

  • Cost effective to produce

  • We are now open to discuss co-investment options and to decide on locating future manufacuring in the EU

Stage

  • Seed and Development
  • Startup

Applies to

  • Biotech, Pharma and Cosmetics
  • Healthcare

Organisation

Branson Pharma AG

Baar, Switzerland

Similar opportunities